Coloplast Hits 15-Week Low as Lawsuits Loom: Copenhagen Mover
This article is for subscribers only.
Coloplast A/S fell to its lowest in more than three months in Copenhagen trading after risks rose the Danish medical device maker may lose legal battles over a product for treating pelvic organ prolapse and incontinence.
Coloplast fell as much as 1.8 percent to 306 kroner, its lowest level since May 2. The share declined 1.6 percent, or 5 kroner, to 306.50 kroner at 10:51 a.m. local time. Trading volume was 30 percent of the three-month daily average. The stock was the worst performing in the benchmark OMX Copenhagen index.